International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical MedicineEUFEMED and HEALIXIA are jointly organizing a conference in Mechelen (Belgium), on May 21st, 22nd & 23rd 2025. You can find more info on the webpage of the conference.
The conference aims at providing a forum for joint discussions on how best to deal with our current conflicting situation: while achieving simplicity is considered a pre-requisite by ICH-GCP(R2) for improving trial performance and reducing costs, we experience that the complexity of science, methodology and regulatory requirements rapidly increase. The move into genetic medicines, the impact of AI in drug development, the demand for diversity and the changing regulatory and market access environment are just a few of the challenges we are facing.
EUFEMED is European Federation for Exploratory Medicines Development) Ten years ago EUFEMED was founded by 4 national European human pharmacology associations: BAPU in Belgium, Club Phase I in France, AGAH in Germany and AHPPI in the United Kingdom to progress science and methodology in human pharmacology on a European level and to increase awareness for the importance and specific needs of exploratory medicines development. More info on www.eufemed.eu
HEALIXIA is the Belgian community of all professionals active along the life cycle of medicines, medical devices, in vitro diagnostics & other health related products. Members are active in research & development (including pre-clinical, early clinical and later phases), medical affairs, safety, regulatory affairs and market access in industry, academia, investigator sites, authorities, regulatory bodies or in consultancy. HEALIXIA is a member of IFAPP. More info on www.healixia.be
This joint EUFEMED – HEALIXIA conference is a special edition as both organisations celebrate an anniversary: 10 years of EUFEMED and 5 years of HEALIXIA.
